Bioanalytical Methods to Optimize Drug Development: Hybrid LC-MS vs LBA

Author(s):

KCAS Bioanalytical and Biomarker Services

Drs Dawn Dufield and Dominic Warrino, KCAS Bioanalytical and Biomarker Services, share expertise on using Hybrid LC-MS versus LBA for bioanalytical analysis.

Selecting the right bioanalytical method to support qualitative and quantitative analysis requires flexibility and expertise from a CRO equipped to adapt to industry advancements.

Learn more:

Understand when to use LC-MS, LBA or both.
Learn why keeping LBA and Hybrid LC-MS in the forefront of your studies can result in big benefits.
Understand the best method to optimize your drug development outcomes.

See the entire 45-minute deep-dive broken into an 11-part video series,

here.

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!